# Developmental Core (Core B)

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2022 · $746,336

## Abstract

Developmental Core – PROJECT SUMMARY
The Tennessee Center for AIDS Research (CFAR) is a four-way partnership between a research-intensive
institution (Vanderbilt University Medical Center), a historically black medical college (Meharry Medical College),
an academically-engaged state health department (Tennessee Department of Health), and a sophisticated
community-based organization with a 25-year exclusive focus on HIV (Nashville CARES). The Developmental
Core (DC) will support and enhance collaborative, interdisciplinary HIV/AIDS research at the four partner
institutions. Invigorated by new DC initiatives and leadership, the DC will pursue three complementary objectives:
1) To administer a robust CFAR DC Awards program that supports interdisciplinary HIV research projects and
new HIV research pilot projects; 2) To ensure mentoring of investigators new to HIV research, with a focus on
early stage, minority, women, and public health investigators, to enhance competitiveness for extramural funding,
and; 3) To foster academic skills development and scientific team-building. In 2019, the DC leadership structure
transitioned, with John Koethe, MD, MSCI, Associate Professor of Medicine at Vanderbilt, assuming the role of
DC Director, supported by Fernando Villalta, PhD and Tim Sterling, MD as Associate Directors. This change was
in response to extensive strategic planning, with input from the our CFAR External and Internal Scientific
Advisory Boards, as part of succession planning for the upcoming funding cycle of this CFAR. The DC will not
only provide DC Award funding for promising early-stage investigators but will continue to assure that there is
appropriate mentoring together with activities to foster team building. This will help early-stage investigators
appreciate the critical importance of effective collaboration as they develop into accomplished academic
research scientists. The HIV-focused DC Awards, mentoring, and skills development will be leveraged with
outstanding institutional support at Vanderbilt (through the Vanderbilt Institute for Clinical and Translational
Research; VICTR) and at Meharry (through the Meharry Translational Research Center; MeTRC, and the Center
for Health Disparities Research at MMC) to maximize the potential for important, ground-breaking research that
will lead to extramural funding support, and that ultimately has substantial impact on the burden of HIV in
Tennessee, the nation, and worldwide.

## Key facts

- **NIH application ID:** 10404932
- **Project number:** 5P30AI110527-08
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** John Koethe
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $746,336
- **Award type:** 5
- **Project period:** 2015-04-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10404932

## Citation

> US National Institutes of Health, RePORTER application 10404932, Developmental Core (Core B) (5P30AI110527-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10404932. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*